• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高通量黏膜平台的渗透性评估

Permeability Assessment of a High-Throughput Mucosal Platform.

作者信息

Butnarasu Cosmin, Garbero Olga Valentina, Petrini Paola, Visai Livia, Visentin Sonja

机构信息

Department of Molecular Biotechnology and Health Science, University of Turin, via Quarello 15, 10135 Torino, Italy.

Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, 20133 Milan, Italy.

出版信息

Pharmaceutics. 2023 Jan 22;15(2):380. doi: 10.3390/pharmaceutics15020380.

DOI:10.3390/pharmaceutics15020380
PMID:36839702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9966667/
Abstract

Permeability across cellular membranes is a key factor that influences absorption and distribution. Before absorption, many drugs must pass through the mucus barrier that covers all the wet surfaces of the human body. Cell-free in vitro tools currently used to evaluate permeability fail to effectively model the complexity of mucosal barriers. Here, we present an in vitro mucosal platform as a possible strategy for assessing permeability in a high-throughput setup. The PermeaPad 96-well plate was used as a permeability system and further coupled to a pathological, tridimensional mucus model. The physicochemical determinants predicting passive diffusion were determined by combining experimental and computational approaches. Drug solubility, size, and shape were found to be the critical properties governing permeability, while the charge of the drug was found to be influential on the interaction with mucus. Overall, the proposed mucosal platform could be a promising in vitro tool to model the complexity of mucosal tissues and could therefore be adopted for drug-permeability profiling.

摘要

跨细胞膜的通透性是影响吸收和分布的关键因素。在吸收之前,许多药物必须穿过覆盖人体所有湿润表面的黏液屏障。目前用于评估通透性的无细胞体外工具无法有效模拟黏膜屏障的复杂性。在此,我们提出一种体外黏膜平台,作为在高通量设置中评估通透性的一种可能策略。PermeaPad 96孔板用作通透性系统,并进一步与病理性三维黏液模型相结合。通过结合实验和计算方法确定了预测被动扩散的物理化学决定因素。发现药物的溶解度、大小和形状是控制通透性的关键特性,而药物的电荷被发现对与黏液的相互作用有影响。总体而言,所提出的黏膜平台可能是一种很有前景的体外工具,可用于模拟黏膜组织的复杂性,因此可用于药物通透性分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/d241391d16fd/pharmaceutics-15-00380-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/eeff452894cc/pharmaceutics-15-00380-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/1883f04505c2/pharmaceutics-15-00380-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/8344abcbaf9f/pharmaceutics-15-00380-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/f1747347dca3/pharmaceutics-15-00380-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/8e9fe928a35d/pharmaceutics-15-00380-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/d241391d16fd/pharmaceutics-15-00380-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/eeff452894cc/pharmaceutics-15-00380-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/1883f04505c2/pharmaceutics-15-00380-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/8344abcbaf9f/pharmaceutics-15-00380-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/f1747347dca3/pharmaceutics-15-00380-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/8e9fe928a35d/pharmaceutics-15-00380-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ea1/9966667/d241391d16fd/pharmaceutics-15-00380-g006.jpg

相似文献

1
Permeability Assessment of a High-Throughput Mucosal Platform.高通量黏膜平台的渗透性评估
Pharmaceutics. 2023 Jan 22;15(2):380. doi: 10.3390/pharmaceutics15020380.
2
Drug Permeability Profiling Using the Novel Permeapad® 96-Well Plate.采用新型 Permeapad® 96 孔板进行药物渗透特性分析。
Pharm Res. 2020 May 11;37(6):93. doi: 10.1007/s11095-020-02807-x.
3
Cystic Fibrosis Mucus Model to Design More Efficient Drug Therapies.囊性纤维化黏液模型用于设计更有效的药物疗法。
Mol Pharm. 2022 Feb 7;19(2):520-531. doi: 10.1021/acs.molpharmaceut.1c00644. Epub 2021 Dec 22.
4
Mucus-PVPA (mucus Phospholipid Vesicle-based Permeation Assay): An artificial permeability tool for drug screening and formulation development.黏液-PVPA(基于黏液磷脂囊泡的渗透测定法):一种用于药物筛选和制剂开发的人工渗透工具。
Int J Pharm. 2018 Feb 15;537(1-2):213-222. doi: 10.1016/j.ijpharm.2017.12.038. Epub 2017 Dec 26.
5
Physicochemical profiling (solubility, permeability and charge state).物理化学特性分析(溶解度、渗透性和电荷状态)。
Curr Top Med Chem. 2001 Sep;1(4):277-351. doi: 10.2174/1568026013395100.
6
Use of Permeapad® for prediction of buccal absorption: A comparison to in vitro, ex vivo and in vivo method.使用Permeapad®预测口腔吸收:与体外、离体和体内方法的比较。
Eur J Pharm Sci. 2016 Oct 10;93:399-404. doi: 10.1016/j.ejps.2016.08.041. Epub 2016 Aug 24.
7
Mucus as a barrier to lipophilic drugs.黏液作为脂溶性药物的屏障。
Int J Pharm. 2013 Aug 30;453(1):56-64. doi: 10.1016/j.ijpharm.2013.05.040. Epub 2013 May 29.
8
Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery.解析黏液屏障的复杂性,开发快速筛选工具,助力早期药物发现。
J Mater Chem B. 2019 Aug 14;7(32):4940-4952. doi: 10.1039/c9tb00957d.
9
The role of mucus in cell-based models used to screen mucosal drug delivery.用于筛选黏膜药物递送的基于细胞模型中黏液的作用。
Adv Drug Deliv Rev. 2018 Jan 15;124:50-63. doi: 10.1016/j.addr.2017.07.019. Epub 2017 Jul 25.
10
Predicting Oral Absorption of fenofibrate in Lipid-Based Drug Delivery Systems by Combining In Vitro Lipolysis with the Mucus-PVPA Permeability Model.结合体外脂肪酶解和黏膜-PVPA 渗透模型预测脂基给药系统中非诺贝特的口服吸收。
J Pharm Sci. 2021 Jan;110(1):208-216. doi: 10.1016/j.xphs.2020.08.026. Epub 2020 Sep 8.

引用本文的文献

1
Mucosomes as next-generation drug carriers for treating mucus-resident bacterial infections and biofilms.黏液小体作为用于治疗驻留于黏液中的细菌感染和生物膜的下一代药物载体。
Sci Rep. 2025 Jul 25;15(1):27071. doi: 10.1038/s41598-025-10496-y.
2
Nanoparticle tools for maximizing oral drug delivery.用于最大化口服药物递送的纳米颗粒工具。
Braz J Med Biol Res. 2025 Jun 16;58:e14459. doi: 10.1590/1414-431X2025e14459. eCollection 2025.
3
Computational study of phytochemicals from Khaya grandifoliola (WELW) as potential inhibitors of the transketolase and putative antimalarial agents.

本文引用的文献

1
Synthesis and biomedical applications of mucin mimic materials.黏蛋白模拟材料的合成及生物医学应用。
Adv Drug Deliv Rev. 2022 Dec;191:114540. doi: 10.1016/j.addr.2022.114540. Epub 2022 Oct 10.
2
Modulation of Paracellular-like Drug Transport across an Artificial Biomimetic Barrier by Osmotic Stress-Induced Liposome Shrinking.通过渗透压诱导脂质体收缩调节类旁细胞药物跨人工仿生屏障的转运
Pharmaceutics. 2022 Mar 28;14(4):721. doi: 10.3390/pharmaceutics14040721.
3
Cystic Fibrosis Mucus Model to Design More Efficient Drug Therapies.
对大果卡雅楝(WELW)中植物化学物质作为转酮醇酶潜在抑制剂和假定抗疟剂的计算研究。
In Silico Pharmacol. 2025 Jun 13;13(2):87. doi: 10.1007/s40203-025-00378-6. eCollection 2025.
4
Identification of Microbial-Based Natural Products as Potential CYP51 Inhibitors for Eumycetoma Treatment: Insights from Molecular Docking, MM-GBSA Calculations, ADMET Analysis, and Molecular Dynamics Simulations.鉴定基于微生物的天然产物作为治疗足菌肿的潜在CYP51抑制剂:来自分子对接、MM-GBSA计算、ADMET分析和分子动力学模拟的见解
Pharmaceuticals (Basel). 2025 Apr 20;18(4):598. doi: 10.3390/ph18040598.
5
Prodrug Approach as a Strategy to Enhance Drug Permeability.前药策略作为增强药物渗透性的一种方法。
Pharmaceuticals (Basel). 2025 Feb 21;18(3):297. doi: 10.3390/ph18030297.
6
Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach.研究异戊烯基呫吨酮作为酮己糖激酶C亚型潜在抑制剂用于治疗果糖驱动的代谢紊乱:一种综合计算方法。
Pharmaceuticals (Basel). 2025 Jan 18;18(1):126. doi: 10.3390/ph18010126.
7
Tracing the path of Quorum sensing molecules in cystic fibrosis mucus in a biomimetic in vitro permeability platform.在仿生体外渗透平台中追踪群体感应分子在囊性纤维化黏液中的路径。
Sci Rep. 2024 Oct 29;14(1):25907. doi: 10.1038/s41598-024-77375-w.
8
Prediction of drug-drug interactions between roflumilast and CYP3A4/1A2 perpetrators using a physiologically-based pharmacokinetic (PBPK) approach.应用基于生理学的药代动力学(PBPK)方法预测罗氟司特与 CYP3A4/1A2 代谢酶之间的药物相互作用。
BMC Pharmacol Toxicol. 2024 Jan 2;25(1):4. doi: 10.1186/s40360-023-00726-2.
9
The Preparation and Evaluation of Cyanocobalamin Mucoadhesive Sublingual Tablets.氰钴胺黏附性舌下片的制备与评价
Pharmaceuticals (Basel). 2023 Oct 4;16(10):1412. doi: 10.3390/ph16101412.
囊性纤维化黏液模型用于设计更有效的药物疗法。
Mol Pharm. 2022 Feb 7;19(2):520-531. doi: 10.1021/acs.molpharmaceut.1c00644. Epub 2021 Dec 22.
4
Recent Experimental Developments in Studying Passive Membrane Transport of Drug Molecules.研究药物分子被动膜转运的最新实验进展。
Mol Pharm. 2021 Jun 7;18(6):2122-2141. doi: 10.1021/acs.molpharmaceut.1c00009. Epub 2021 Apr 29.
5
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.ADMETlab 2.0:一个集成的在线平台,用于准确全面地预测 ADMET 性质。
Nucleic Acids Res. 2021 Jul 2;49(W1):W5-W14. doi: 10.1093/nar/gkab255.
6
Mucus and Mucin Environments Reduce the Efficacy of Polymyxin and Fluoroquinolone Antibiotics against .黏液和黏蛋白环境降低了多黏菌素和氟喹诺酮类抗生素对……的疗效。
ACS Biomater Sci Eng. 2019 Mar 11;5(3):1189-1194. doi: 10.1021/acsbiomaterials.8b01054. Epub 2019 Feb 22.
7
Drug Permeability Profiling Using the Novel Permeapad® 96-Well Plate.采用新型 Permeapad® 96 孔板进行药物渗透特性分析。
Pharm Res. 2020 May 11;37(6):93. doi: 10.1007/s11095-020-02807-x.
8
Impact of Mucin on Drug Diffusion: Development of a Straightforward in Vitro Method for the Determination of Drug Diffusivity in the Presence of Mucin.黏蛋白对药物扩散的影响:一种用于测定黏蛋白存在下药物扩散系数的简便体外方法的开发。
Pharmaceutics. 2020 Feb 17;12(2):168. doi: 10.3390/pharmaceutics12020168.
9
Sink conditions do not guarantee the absence of saturation effects.汇水条件并不能保证没有饱和效应。
Int J Pharm. 2020 Mar 15;577:119009. doi: 10.1016/j.ijpharm.2019.119009. Epub 2020 Jan 7.
10
Pulmonary Complications of Cystic Fibrosis.囊性纤维化的肺部并发症。
Semin Respir Crit Care Med. 2019 Dec;40(6):804-809. doi: 10.1055/s-0039-1697639. Epub 2019 Oct 28.